Press Releases

ATLANTA and NEW YORK, February 5, 2024–  The American Most cancers Society (ACS) and Pfizer at present introduced the launch of “Change the Odds: Uniting to Enhance Most cancers Outcomes ^TM,” a three-year initiative to bridge the hole in most cancers care disparities. Via $15 million in funding from Pfizer, the initiative goals to enhance well being outcomes in medically underrepresented communities throughout america by enhancing consciousness of and entry to most cancers screenings, scientific trial alternatives, and affected person help and complete navigation. “Change the Odds” will initially deal with breast and prostate most cancers in medically underserved communities, with the potential to broaden to extra most cancers sorts. ACS plans to interact extra companions to increase the attain of the programmatic actions to extra people and deepen the tangible impression in choose communities.

“Most cancers doesn’t discriminate – and neither ought to most cancers care,” stated Chris Boshoff, Chief Oncology Officer and Government Vice President, Pfizer. “Everybody ought to have the identical alternative to entry the most recent advances in care, no matter their background or the place they reside. We’re proud to companion with the American Most cancers Society on a broad, community-focused initiative to achieve folks dwelling with most cancers the place they’re, with urgency, and join them to assets to obtain the care they deserve.”

Breast and prostate most cancers are the most typical kinds of most cancers recognized amongst men and women in america, respectively.^[i] Incidence for each cancers continues to extend nationwide^[ii],[iii] with a better impression for sure races and ethnicities[iv], which will be extra pronounced in city areas.^[v] As well as, folks dwelling in rural areas in america face limitations to accessing most cancers screening and high quality care,[vi] resulting in increased mortality charges.[vii] Emotions of social isolation skilled by folks dwelling with breast or prostate most cancers are related to poorer outcomes^[viii],[ix], underscoring a crucial want for community-centric approaches which might be designed to make a tangible distinction in sufferers’ lives by addressing their entire well being wants, tackling seclusion and offering the assistance they should guarantee well timed entry to scientific advances in care.

“Our purpose of ending most cancers as we all know it, for everybody, together with medically underrepresented communities, can solely be attained via robust and actionable partnerships with a shared imaginative and prescient like ours with Pfizer,” stated Dr. Karen E. Knudsen, CEO of the American Most cancers Society. “Our collaboration will assist unlock ACS’ full potential in addressing well being disparities with measurable, sustainable and systemic options to ship entry to high-quality care and coverings for each particular person.”

ACS will leverage its broad community and have interaction on-the-ground companions to attach people and promote consciousness of no- and low-cost screening and entry to applications and companies via culturally delicate outreach in communities disproportionately impacted by breast and prostate most cancers. ACS goals to speed up entry to at present’s therapies and tomorrow’s scientific developments to “Change the Odds” to drive sustainable options to assist guarantee equitable outcomes for all sufferers.

Via ACS’ in depth evidence-based affected person navigation applications, sufferers will likely be guided via the complexities of their most cancers journey and given info to assist them perceive and entry really useful screening, therapies, neighborhood assets, and emotional help. ACS may also work to empower sufferers and healthcare suppliers in a number of medically underrepresented communities with details about scientific trials and handle potential limitations to trial participation. Moreover, ACS will work alongside its huge community of Well being Fairness Ambassadors to ship trusted most cancers prevention and early detection assets and data into every neighborhood.

For extra details about “Change the Odds” please go to most cancers.org/ChangeTheOdds.

Key Statistics:

• In line with the most recent analysis from ACS, about 299,000 males will likely be recognized with prostate most cancers in 2024, with greater than 35,000 deaths.[x] The incidence of prostate most cancers is about 70% increased in Black males than in White males.[xi] Black males are over two instances extra more likely to die from the illness than White, Hispanic or Asian American/Pacific Islander males.^xi 
• Practically 311,000 ladies will likely be recognized with breast most cancers this yr, with greater than 42,000 deaths. ^x
• Regardless of having a 4 p.c decrease incidence of breast most cancers, Black ladies with breast most cancers are 40% extra more likely to die than White ladies and twice as more likely to die if they’re youthful than the age of fifty.^[xii] Hispanic ladies usually tend to be recognized with later-staged breast most cancers compared to White ladies.^[xiii]
• Whereas there was progress in most cancers prevention, early detection, and therapy in america, people who find themselves of decrease socioeconomic standing and dwelling in rural areas haven’t benefited equitably from these advances. [xiv] Usually, survival after a most cancers prognosis is shorter for folks of all races who’ve a decrease socioeconomic standing and who reside in a extra rural space than those that don’t. ^xiv
• Though most cancers can disproportionately impression ethnic/racial teams in each incidence and consequence, racial minorities are much less more likely to be included in scientific trials.^iv 
• These dwelling in rural areas typically expertise transportation challenges and different limitations to scientific trial participation.^vi

About The American Most cancers Society

The American Most cancers Society is a number one cancer-fighting group with a imaginative and prescient to finish most cancers as we all know it, for everybody. For greater than 100 years, we have now been bettering the lives of individuals with most cancers and their households as the one group combating most cancers via advocacy, analysis, and affected person help.  We’re dedicated to making sure everybody has a possibility to stop, detect, deal with, and survive most cancers. To be taught extra, go to most cancers.org or name our 24/7 helpline at 1-800-227-2345. Join with us on Fb, Twitter, and Instagram.

About Pfizer Oncology

At Pfizer Oncology, we’re on the forefront of a brand new period in most cancers care. Our industry-leading portfolio and in depth pipeline consists of game-changing mechanisms of motion to assault most cancers from a number of angles, together with antibody-drug conjugates (ADCs), small molecules, bispecifics and different immunotherapies. We’re targeted on delivering transformative therapies in a few of the world’s commonest cancers, together with breast most cancers, genitourinary most cancers and hematologic malignancies, in addition to melanoma, gastrointestinal, gynecological and thoracic cancers, which incorporates lung most cancers. Pushed by science, we’re dedicated to accelerating breakthroughs to increase and enhance sufferers’ lives.

Enterprise Wire Launch